Glossary
What is ANDA?
An Abbreviated New Drug Application, submitted to the US FDA for approval of a generic medicine. Rather than repeating clinical trials, the applicant demonstrates pharmaceutical equivalence and bioequivalence to a reference listed drug. ANDA filings rely on detailed chemistry, manufacturing and controls data, including impurity profiles supported by characterised impurity reference standards and, frequently, a referenced Drug Master File for the API.